pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4323 |
Genomic Coordinates | chr19: 42133445 - 42133513 |
Description | Homo sapiens miR-4323 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4323 | ||||||||||||||||||
Sequence | 42| CAGCCCCACAGCCUCAGA |59 | ||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||
Experiments | SOLiD | ||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | ABCC5 | ||||||||||||||||||||
Synonyms | ABC33, EST277145, MOAT-C, MOATC, MRP5, SMRP, pABC11 | ||||||||||||||||||||
Description | ATP binding cassette subfamily C member 5 | ||||||||||||||||||||
Transcript | NM_005688 | ||||||||||||||||||||
Other Transcripts | NM_001023587 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on ABCC5 | |||||||||||||||||||||
3'UTR of ABCC5 (miRNA target sites are highlighted) |
>ABCC5|NM_005688|3'UTR 1 CTCCTCCCTGTTGACGAAGTCTCTTTTCTTTAGAGCATTGCCATTCCCTGCCTGGGGCGGGCCCCTCATCGCGTCCTCCT 81 ACCGAAACCTTGCCTTTCTCGATTTTATCTTTCGCACAGCAGTTCCGGATTGGCTTGTGTGTTTCACTTTTAGGGAGAGT 161 CATATTTTGATTATTGTATTTATTCCATATTCATGTAAACAAAATTTAGTTTTTGTTCTTAATTGCACTCTAAAAGGTTC 241 AGGGAACCGTTATTATAATTGTATCAGAGGCCTATAATGAAGCTTTATACGTGTAGCTATATCTATATATAATTCTGTAC 321 ATAGCCTATATTTACAGTGAAAATGTAAGCTGTTTATTTTATATTAAAATAAGCACTGTGCTAATAACAGTGCATATTCC 401 TTTCTATCATTTTTGTACAGTTTGCTGTACTAGAGATCTGGTTTTGCTATTAGACTGTAGGAAGAGTAGCATTTCATTCT 481 TCTCTAGCTGGTGGTTTCACGGTGCCAGGTTTTCTGGGTGTCCAAAGGAAGACGTGTGGCAATAGTGGGCCCTCCGACAG 561 CCCCCTCTGCCGCCTCCCCACGGCCGCTCCAGGGGTGGCTGGAGACGGGTGGGCGGCTGGAGACCATGCAGAGCGCCGTG 641 AGTTCTCAGGGCTCCTGCCTTCTGTCCTGGTGTCACTTACTGTTTCTGTCAGGAGAGCAGCGGGGCGAAGCCCAGGCCCC 721 TTTTCACTCCCTCCATCAAGAATGGGGATCACAGAGACATTCCTCCGAGCCGGGGAGTTTCTTTCCTGCCTTCTTCTTTT 801 TGCTGTTGTTTCTAAACAAGAATCAGTCTATCCACAGAGAGTCCCACTGCCTCAGGTTCCTATGGCTGGCCACTGCACAG 881 AGCTCTCCAGCTCCAAGACCTGTTGGTTCCAAGCCCTGGAGCCAACTGCTGCTTTTTGAGGTGGCACTTTTTCATTTGCC 961 TATTCCCACACCTCCACAGTTCAGTGGCAGGGCTCAGGATTTCGTGGGTCTGTTTTCCTTTCTCACCGCAGTCGTCGCAC 1041 AGTCTCTCTCTCTCTCTCCCCTCAAAGTCTGCAACTTTAAGCAGCTCTTGCTAATCAGTGTCTCACACTGGCGTAGAAGT 1121 TTTTGTACTGTAAAGAGACCTACCTCAGGTTGCTGGTTGCTGTGTGGTTTGGTGTGTTCCCGCAAACCCCCTTTGTGCTG 1201 TGGGGCTGGTAGCTCAGGTGGGCGTGGTCACTGCTGTCATCAATTGAATGGTCAGCGTTGCATGTCGTGACCAACTAGAC 1281 ATTCTGTCGCCTTAGCATGTTTGCTGAACACCTTGTGGAAGCAAAAATCTGAAAATGTGAATAAAATTATTTTGGATTTT 1361 GTAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545215. RNA binding protein: AGO4. Condition:Control
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 10057.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714645. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | hESCs (WA-09) |
Disease | 10057.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in SRR359787. RNA binding protein: AGO2. Condition:4-thiouridine
... - Lipchina I; Elkabetz Y; Hafner M; Sheridan et al., 2011, Genes & development. |
Article |
- Lipchina I; Elkabetz Y; Hafner M; Sheridan et al. - Genes & development, 2011
MicroRNAs are important regulators in many cellular processes, including stem cell self-renewal. Recent studies demonstrated their function as pluripotency factors with the capacity for somatic cell reprogramming. However, their role in human embryonic stem (ES) cells (hESCs) remains poorly understood, partially due to the lack of genome-wide strategies to identify their targets. Here, we performed comprehensive microRNA profiling in hESCs and in purified neural and mesenchymal derivatives. Using a combination of AGO cross-linking and microRNA perturbation experiments, together with computational prediction, we identified the targets of the miR-302/367 cluster, the most abundant microRNAs in hESCs. Functional studies identified novel roles of miR-302/367 in maintaining pluripotency and regulating hESC differentiation. We show that in addition to its role in TGF-beta signaling, miR-302/367 promotes bone morphogenetic protein (BMP) signaling by targeting BMP inhibitors TOB2, DAZAP2, and SLAIN1. This study broadens our understanding of microRNA function in hESCs and is a valuable resource for future studies in this area.
LinkOut: [PMID: 22012620]
|
Experimental Support 4 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 10057.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065668. RNA binding protein: AGO1. Condition:4-thiouridine
"PAR-CLIP data was present in GSM1065669. RNA binding protein: AGO1. Condition:4-thiouridine
"PAR-CLIP data was present in GSM1065670. RNA binding protein: AGO2. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
CLIP-seq Support 1 for dataset GSM4903825 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / PID14_NS |
Location of target site | NM_005688 | 3UTR | AAACCCCCUUUGUGCUGUGGGGCUGGUAGCUCAGGUGGGCGUGGUCACUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161237 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_005688 | 3UTR | GCUGUGGGGCUGGUAGCUCAGGUGGGCGUGGUCACUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM545215 | |
---|---|
Method / RBP | PAR-CLIP / AGO4 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000334444.6 | 3UTR | GGGCUGGUAGCUCAGGUGG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM714645 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repB |
Location of target site | ENST00000334444.6 | 3UTR | GGGCUGGUAGCUCAGGUGGG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset SRR359787 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | hESCs (WA-09) / 4-thiouridine, RNase T1 |
Location of target site | ENST00000334444.6 | 3UTR | GGGCUGGUAGCUCAGGUGGGC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22012620 / SRX103431 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM1065668 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_7 |
Location of target site | ENST00000334444.6 | 3UTR | GGGCUGGUAGCUCAGGUGG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM1065669 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_8 |
Location of target site | ENST00000334444.6 | 3UTR | GGGCUGGUAGCUCAGGUGGG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
CLIP-seq Support 8 for dataset GSM1065670 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / 4-thiouridine, 3_ML_LG |
Location of target site | ENST00000334444.6 | 3UTR | GGGCUGGUAGCUCAGGUGG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
64 hsa-miR-4323 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT052834 | NOL11 | nucleolar protein 11 | 1 | 1 | ||||||||
MIRT082489 | PPP1R37 | protein phosphatase 1 regulatory subunit 37 | 2 | 2 | ||||||||
MIRT117166 | PER1 | period circadian clock 1 | 2 | 2 | ||||||||
MIRT157951 | TMEM184B | transmembrane protein 184B | 2 | 2 | ||||||||
MIRT286013 | TVP23B | trans-golgi network vesicle protein 23 homolog B | 2 | 2 | ||||||||
MIRT310457 | REST | RE1 silencing transcription factor | 2 | 2 | ||||||||
MIRT338984 | CPSF6 | cleavage and polyadenylation specific factor 6 | 2 | 2 | ||||||||
MIRT404223 | RPL7L1 | ribosomal protein L7 like 1 | 2 | 2 | ||||||||
MIRT451439 | TJP3 | tight junction protein 3 | 2 | 2 | ||||||||
MIRT463541 | ZBTB7A | zinc finger and BTB domain containing 7A | 2 | 2 | ||||||||
MIRT466981 | STARD7 | StAR related lipid transfer domain containing 7 | 2 | 4 | ||||||||
MIRT479627 | CDC25A | cell division cycle 25A | 2 | 2 | ||||||||
MIRT487983 | SEC14L3 | SEC14 like lipid binding 3 | 2 | 4 | ||||||||
MIRT488661 | ELAVL3 | ELAV like RNA binding protein 3 | 2 | 2 | ||||||||
MIRT489925 | RTKN | rhotekin | 2 | 2 | ||||||||
MIRT490209 | PKNOX2 | PBX/knotted 1 homeobox 2 | 2 | 2 | ||||||||
MIRT494896 | ZNF662 | zinc finger protein 662 | 2 | 2 | ||||||||
MIRT495380 | RELT | RELT, TNF receptor | 2 | 2 | ||||||||
MIRT495549 | ANKRD65 | ankyrin repeat domain 65 | 2 | 2 | ||||||||
MIRT499104 | AGRN | agrin | 2 | 2 | ||||||||
MIRT500036 | ABCF2 | ATP binding cassette subfamily F member 2 | 2 | 8 | ||||||||
MIRT501135 | SLC2A1 | solute carrier family 2 member 1 | 2 | 2 | ||||||||
MIRT505573 | SMC1A | structural maintenance of chromosomes 1A | 2 | 6 | ||||||||
MIRT508164 | ABCC5 | ATP binding cassette subfamily C member 5 | 2 | 8 | ||||||||
MIRT512383 | PHB2 | prohibitin 2 | 2 | 2 | ||||||||
MIRT512719 | YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta | 2 | 2 | ||||||||
MIRT520904 | STMN1 | stathmin 1 | 2 | 2 | ||||||||
MIRT526361 | TIMMDC1 | translocase of inner mitochondrial membrane domain containing 1 | 2 | 2 | ||||||||
MIRT526847 | GALNT11 | polypeptide N-acetylgalactosaminyltransferase 11 | 2 | 2 | ||||||||
MIRT526945 | CMSS1 | cms1 ribosomal small subunit homolog (yeast) | 2 | 4 | ||||||||
MIRT527028 | PABPN1L | poly(A) binding protein nuclear 1 like, cytoplasmic | 2 | 2 | ||||||||
MIRT527988 | TSLP | thymic stromal lymphopoietin | 2 | 2 | ||||||||
MIRT532202 | MPDU1 | mannose-P-dolichol utilization defect 1 | 2 | 2 | ||||||||
MIRT533691 | TMEM86A | transmembrane protein 86A | 2 | 2 | ||||||||
MIRT535020 | PRMT7 | protein arginine methyltransferase 7 | 2 | 4 | ||||||||
MIRT535054 | PQLC1 | PQ loop repeat containing 1 | 2 | 2 | ||||||||
MIRT538987 | BCL2L2 | BCL2 like 2 | 2 | 2 | ||||||||
MIRT552232 | SART3 | squamous cell carcinoma antigen recognized by T-cells 3 | 2 | 2 | ||||||||
MIRT553259 | TVP23C | trans-golgi network vesicle protein 23 homolog C | 2 | 2 | ||||||||
MIRT555157 | PTPDC1 | protein tyrosine phosphatase domain containing 1 | 2 | 2 | ||||||||
MIRT565202 | TSC22D4 | TSC22 domain family member 4 | 2 | 2 | ||||||||
MIRT566199 | PTP4A1 | protein tyrosine phosphatase type IVA, member 1 | 2 | 2 | ||||||||
MIRT566526 | PARP16 | poly(ADP-ribose) polymerase family member 16 | 2 | 2 | ||||||||
MIRT568464 | ARPP19 | cAMP regulated phosphoprotein 19 | 2 | 2 | ||||||||
MIRT572231 | ATG2A | autophagy related 2A | 2 | 2 | ||||||||
MIRT573096 | NDUFA7 | NADH:ubiquinone oxidoreductase subunit A7 | 2 | 2 | ||||||||
MIRT573326 | RFC5 | replication factor C subunit 5 | 2 | 2 | ||||||||
MIRT632802 | KIAA2022 | neurite extension and migration factor | 2 | 2 | ||||||||
MIRT646433 | ARAP1 | ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 | 2 | 3 | ||||||||
MIRT647826 | MTG1 | mitochondrial ribosome associated GTPase 1 | 2 | 4 | ||||||||
MIRT652191 | TRIM44 | tripartite motif containing 44 | 2 | 2 | ||||||||
MIRT653800 | SIRPA | signal regulatory protein alpha | 2 | 2 | ||||||||
MIRT666949 | PKHD1 | PKHD1, fibrocystin/polyductin | 2 | 2 | ||||||||
MIRT684833 | SCAI | suppressor of cancer cell invasion | 2 | 2 | ||||||||
MIRT687294 | PARP2 | poly(ADP-ribose) polymerase 2 | 2 | 2 | ||||||||
MIRT700188 | RIMKLB | ribosomal modification protein rimK like family member B | 2 | 2 | ||||||||
MIRT701784 | MSL2 | MSL complex subunit 2 | 2 | 2 | ||||||||
MIRT705958 | ACY1 | aminoacylase 1 | 2 | 2 | ||||||||
MIRT705998 | ABHD14A-ACY1 | ABHD14A-ACY1 readthrough | 2 | 2 | ||||||||
MIRT717107 | PXDC1 | PX domain containing 1 | 2 | 2 | ||||||||
MIRT717586 | VTA1 | vesicle trafficking 1 | 2 | 2 | ||||||||
MIRT722148 | SLC2A8 | solute carrier family 2 member 8 | 2 | 2 | ||||||||
MIRT723479 | WIPF2 | WAS/WASL interacting protein family member 2 | 2 | 2 | ||||||||
MIRT725221 | PEA15 | phosphoprotein enriched in astrocytes 15 | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|